SANDRA
RODRÍGUEZ PERALES
Profesora asociada
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (15)
2023
-
A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Blood, Vol. 142, Núm. 20, pp. 1752-1756
-
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
British Journal of Haematology
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
-
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma
Nature Communications, Vol. 14, Núm. 1
2021
-
Alterations in slc4a2, slc26a7 and slc26a9 drive acid–base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario
Cells, Vol. 10, Núm. 12
-
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
Nature Cancer, Vol. 2, Núm. 12, pp. 1387-1405
2020
-
Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL
Blood, Vol. 136, Núm. 3, pp. 313-327
-
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
Nature Communications, Vol. 11, Núm. 1
-
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
Molecular Therapy - Nucleic Acids, Vol. 20, pp. 196-204
-
TALEN mediated gene editing in a mouse model of Fanconi anemia
Scientific Reports, Vol. 10, Núm. 1
2019
-
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
Cell Stem Cell, Vol. 25, Núm. 5, pp. 607-621.e7
2018
-
CRISPR/Cas9 for cancer therapy: Hopes and challenges
Biomedicines, Vol. 6, Núm. 4
2017
-
Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
Stem Cell Reports, Vol. 8, Núm. 5, pp. 1408-1420
-
Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus
Stem Cell Research, Vol. 21, pp. 137-140
-
Modeling mixed-lineage-rearranged leukemia initiation in CD34+ cells: A “CRISPR” solution
Haematologica